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Exploring The Human
Hepatocirrhosis Virus
Dawilmer Castillo

T

he Human Hepatocirrhosis Virus (HHV) infection
of human hepatocyte cells leads to massive cell death
that ultimately causes liver failure, a life threatening
condition that demands urgent medical care. In the United
States alone, HHV is responsible for approximately 2,800
deaths each year and causes irreversible tissue damage that
affects over 8,200 people that will require lifelong treatment.
Most often, liver failure occurs gradually over many years
following HHV infection. The symptoms of the disease are
swollen abdomen, mental disorientation, and even coma.
To prevent infection from the HHV virus one should
practice proper hygiene and safe sex and avoid consuming
contaminated food and water. Understanding the functions,
structure, mechanical processes and characteristics of HHV
is crucial for early detection, treatment, and the development
of a potential vaccine for the virus.
Pathology
HHV enters the human body through the mucosa of the
mouth, nose, genital area, or open wounds in the skin; however,
most infections originate from consumption of contaminated
food or water. After the virus enters the body, it travels
through the bloodstream until it reaches the hepatocytes in
the liver (Figure 1a). Once it encounters the hepatocytes,
HHV infects cells by binding to a specific receptor unique
to hepatocytes and starts making copies of itself. The newly
assembled viral particles exit the host cell and propagate
into neighboring hepatocytes, causing massive cell death.
This activates the immune system, which fight the spread of
the virus and causes inflammation of the liver (Figure 1b).
Since HHV propagates very fast it mutates frequently thus
preventing the body from building long-lasting immunity
to the virus. The viral infection and the constant release of
chemicals by the immune system results in cirrhosis of the
liver. Histologically, the HHV damage resembles liver damage
by Hepatitis viruses, as shown in Figure 1. The liver does not
have sufficient time to heal itself thus forming cirrhotic tissue.
A cirrhotic liver cannot effectively synthesize proteins, filter
the blood or regulate blood sugar levels. If left untreated,
the loss of liver functions may cause death and other serious
complications such as cancer. 8
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Virion Characteristics
The Human Hepatocirrhosis Virus is an enveloped virus with
icosahedral shape (Figure 2a) with an approximate size of 40 to
60nm. The virus also has the tegument, comprised of proteins
that line the space between the envelope and the nucleocapsid
(Figure 2b). These proteins mainly contribute to viral RNA
replication, the elimination of cellular competition and the
evasion of the immune response. Dawicasmer12 (DCM12)
and Rocasmer14 (RC14) are glycoproteins present on the
surface of the envelope and play an important role for viral
attachment and entry to the host cell (Figure 2c). HHV has
a negative sense single stranded RNA genome, which is linear
and nonsegmented. The genome is relatively small (95kB),
thus the virus has evolved several mechanisms to code as many
functional proteins as possible as discussed below.
Virus Life Cycle and Interaction with Host Cell
After HHV enters the human body, the virus glycoprotein
ligands (DCM12 and RC14) will bind to complementarily
receptors on the surface of hepatocyte cells named DCM12-C
and RC14-C. Next, the host cell engulfs the virion via enclosure
into the cellular membrane forming a vesicle and intaking the
HHV virus into the cytoplasm of the cell in a process called
receptor-mediated endocytosis. Once inside of the cell, HHV
will activate its M2 channels that will change the pH of the
intracellular environment, disassociating the virion envelope,
capsid and cellular vesicle. Release of the HHV RNA genome
into the cytoplasm will start viral protein synthesis and
replication using cellular machinery (Figure 3). The replicated
HHV genome is packaged inside a newly synthesized capsid.
The virus maturation and release will then follow with new
HHV virions exiting the host cell via budding. The release
of new HHV progeny allows for further infection of healthy
cells, repeating the process (Figure 4). 5, 6
HHV Replication and Translation
HHV needs a RNA-dependent RNA-polymerase to replicate
its negative sense ssRNA genome, an enzyme not found in
animal cells. The virus codes for its own RNA-dependent
RNA-polymerase and packages a functional enzyme in each
virion. To start replication, the viral polymerase complex reads
the (-)ssRNA genome 3’ to 5’ direction and it synthesizes
the complementary (+)ssRNA strand 5’ to 3’ direction. The
same polymerase complex will then read the (+)ssRNA and
synthesize a new complementary (-)ssRNA strand (Figure 5a)
which is then ready to be packaged in a capsid. 6
The virion RNA is negative sense (complementary to mRNA)
and must therefore be copied into the complementary (+)
ssRNA before viral proteins can be synthesized. (+)ssRNA is
the same sense as cellular mRNA so it functions as a regular
mRNA molecule. The newly synthesized viral (+)ssRNA
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Effects of Viral Infection in the Liver

Figure 1. Histological appearance of hepatocytes isolated from an individual infected with HHV at different stages of progression during viral infection.
A) Micrograph depicts normal/healthy liver tissue before viral infection; (B) inflamed/fibrotic tissue as occurs upon infection; and (C) cirrhotic
hepatocytes after repetitive exposure to HHV and the activation immune system.

Virion Characteristics

Figure 2. Model of the Human Hepatocirrhosis virus.
A virion constructed by using a 4-inch Styrofoam white ball and manually pinning gold and silver thumbstacks in a circular pattern. (A) The envelope of
the virus is depicted by different thumbstack colors to represent the different proteins found in the envelope of the virion; (B) is a cross section image
of the HHV virus made by cutting a Styrofoam white ball in half and painting the inside with black marker to represent the viral tegument. A red nylon
chenille stem was then glued in the middle of the styrofoam ball which represents the -ssRNA genome of HHV that is encapsulated by the capsid (not
depicted); (C) is a HHV model stained with green fluorescent dye (glow stick liquid) to represent the glycoproteins present on the surface of the virus used
for identification of hepatocyte cells.

can be translated by cellular ribosomes resulting in protein
synthesis (Figure 5b). It is critical for HHV to code for RNAdependent RNA-polymerase in its genome and also package
it in the virion capsid so that the polymerase can synthesize
(+)ssRNAs upon infecting the cell so that translation and
replication can occur. 6
Evolutionary Gadgets
HHV has a relatively small genome thus it can only code for
few proteins. To overcome this, HHV has evolved several
BRIDGEWATER STATE UNIVERSITY

traits that allow it to compensate for its small genome
and successfully compete with cellular molecules. HHV is
polycistronic, meaning that a single viral mRNA molecule
encodes for several different polypeptide chains. When the
viral mRNA gets translated into proteins, multiple proteins
are bound together. The viral mRNA is translated into large
molecules in which multiple proteins are connected together
into a polyprotein. Enzymes called proteases cleave the huge
polyprotein resulting into separation of the individual pieces.
HHV also encodes for viral de-capping enzymes that degrade
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Figure 3. Schematic of the mechanism for HHV viral replication and protein
synthesis. The HHV virus has a (-) ssRNA DNA that is synthesized into
its complementary (+) ssRNA strand. The (+) ssRNA strand can then be
translated (protein synthesis) by cellular machinery and replicated (formation
of a newly synthesized viral genome). This results in the assembly of a new
virus which will exit the host cell and infect new cells.

Figure 4. Schematic of HHV lytic life cycle and virus/host interaction at the
cellular level. a) Virus binding (adsorption) and internalization (penetration,
entry), b) cytoplasmic release and uncoating, c) IRES-mediated translation
and polyprotein processing that directs the virus to the host endoplasmic
reticulum, d) RNA replication (biosynthesis), e) packaging and assembly, f)
virion maturation and release.4

the CAP structure of cellular mRNAs preventing them from
being translated. This allows HHV mRNAs to be translated
faster than cellular mRNAs. The virus can also use the CAP
from the degraded cellular mRNAs and add it to its own
mRNA molecules. 6 In addition, the viral mRNA has internal
ribosomal entry site (IRES). This is a unique structure in the
mRNA molecule of the virus allowing it to bypass the need
of a CAP at the 5’ end of the mRNA molecule in order for
translation to occur. Thus, cellular machinery would translate

the sequence because IRES will mimic the CAP structure. Viral
polyA polymerase adds a poly-A tail to all viral mRNAs. These
evolutionary gadgets allow HHV to replicate and synthesize
proteins efficiently by utilizing cellular machineries. 6
Immune Response and Genomic Changes
Due to a high mutation rate during HHV replication,
the immune system is relatively inefficient. The lack of
proofreading activity during viral replication results in genetic

HHV Replication and Translation

Figure 5. Schematic of HHV replication and translation. HHV has its own transcription and replication factors that allows proper synthesis of (-)ssRNA
copies and proteins. (A) The (-)ssRNA from HHV gets synthesized to (+)ssRNA by a polymerase complex. Once it is a (+)ssRNA strand, the polymerase
complex can replicate a new (-)ssRNA strand.9 (B) The complementary (+)ssRNA is translated and different proteins are synthesized using cellular
machinery.1 The diagram in panel A originally appeared in Viralzone/Expasy database9.

38 • THE UNDERGRADUATE REVIEW • 2015

BRIDGEWATER STATE UNIVERSITY

drift, which is the change in the frequency of a gene variant in
a population. The majority of these mutations continuously
change the structure of the HHV virus, resulting in an
activation of a new immunological response for the same
virus. Thus, the antibodies that initially recognize and attack
HHV no longer activate the immune system, therefore the
immune system has to generate new antibodies, which takes
time. By then, the virus has already gained new mutations,
therefore, repeating the cycle. HHV can also inhibit the
expression of the major histocompatibility molecule I (MHC
I), which displays fragments of viral proteins from within the
cell to the cell surface so that the immune system can then
identify and attack the infected cell. Without MHC I the cells
of the immune system become practically blind for the virus.
By inhibiting MHC I, HHV is allotted more time to propagate
under the radar of the immune system, thus causing extensive
damage to the liver. 6
Currently, there are no vaccines to combat this pathogen,
however, there are medications that can decrease the propagation
rate of the virus to new cells. A hypothetical antiretroviral drug
called Dawilcasmer prevents HHV infection by binding to the
hepatocyte receptor (DCM12-C), which unable the virus from
binding to this glycoprotein and entering the host cell. HHV
receptor DCM12 has to complimentary bind to a DCM12-C
receptor in hepatocytes in order to enter the cell. However,
this interaction gets disrupted by Dawilcasmer that acts as
antagonist molecule that binds to the DCM12-C receptor,
preventing the HHV from binding to the DCM12-C receptor
and entering the cell. 2
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